Literature DB >> 33642901

Clinical Characteristics of Fragile X Syndrome Patients in Japan.

Tetsuya Okazaki1, Kaori Adachi2, Kaori Matsuura1, Yoshitaka Oyama3, Madoka Nose4, Emi Shirahata5, Toshiaki Abe6, Takeshi Hasegawa7, Toshiro Maihara8, Yoshihiro Maegaki1,9, Eiji Nanba1,10.   

Abstract

BACKGROUND: Fragile X syndrome (FXS) is a well-known X-linked disorder clinically characterized by intellectual disability and autistic features. However, diagnosed Japanese FXS cases have been fewer than expected, and clinical features of Japanese FXS patients remain unknown.
METHODS: We evaluated the clinical features of Japanese FXS patients using the results of a questionnaire-based survey.
RESULTS: We presented the characteristics of seven patients aged 6 to 20 years. Long face and large ears were observed in five of seven patients. Macrocephaly was observed in four of five patients. The meaningful word was first seen at a certain time point between 18 and 72 months (median = 60 months). Developmental quotient or intellectual quotient ranged between 20 and 48 (median = 29). Behavioral disorders were seen in all patients (autistic spectrum disorder in six patients, hyperactivity in five patients). Five patients were diagnosed by polymerase chain reaction analysis, and two patients were diagnosed by the cytogenetic study. All physicians ordered FXS genetic testing for suspicious cases because of clinical manifestations.
CONCLUSION: In the present study, a long face, large ears, macrocephaly, autistic spectrum disorder, and hyperactivity were observed in almost cases, and these characteristics might be common features in Japanese FXS patients. Our finding indicated the importance of clinical manifestations to diagnosis FXS. However, the sample size of the present study is small, and these features are also seen to patients with other disorders. We consider that genetic testing for FXS should be performed on a wider range of intellectually disabled cases. ©2021 Tottori University Medical Press.

Entities:  

Keywords:  CGG repeat expansion; FMR1 gene; fragile X syndrome; genetic testing; intellectual disability

Year:  2021        PMID: 33642901      PMCID: PMC7902172          DOI: 10.33160/yam.2021.02.005

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  12 in total

Review 1.  Comprehensive evaluation of the child with intellectual disability or global developmental delays.

Authors:  John B Moeschler; Michael Shevell
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

2.  Non-radioactive DNA diagnosis for the fragile X syndrome in mentally retarded Japanese males.

Authors:  E Nanba; Y Kohno; A Matsuda; M Yano; C Sato; K Hashimoto; T Koeda; K Yoshino; M Kimura; Y Maeoka
Journal:  Brain Dev       Date:  1995 Sep-Oct       Impact factor: 1.961

3.  A Japanese case of fragile-X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Kazuhiro Ishii; Ai Hosaka; Kaori Adachi; Eiji Nanba; Akira Tamaoka
Journal:  Intern Med       Date:  2010-06-15       Impact factor: 1.271

4.  Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome.

Authors:  Angélique Quartier; Hélène Poquet; Brigitte Gilbert-Dussardier; Massimiliano Rossi; Anne-Sophie Casteleyn; Vincent des Portes; Claire Feger; Elsa Nourisson; Paul Kuentz; Claire Redin; Julien Thevenon; Anne-Laure Mosca-Boidron; Patrick Callier; Jean Muller; Gaetan Lesca; Frédéric Huet; Véronique Geoffroy; Salima El Chehadeh; Matthieu Jung; Benoit Trojak; Stéphanie Le Gras; Daphné Lehalle; Bernard Jost; Stéphanie Maury; Alice Masurel; Patrick Edery; Christel Thauvin-Robinet; Bénédicte Gérard; Jean-Louis Mandel; Laurence Faivre; Amélie Piton
Journal:  Eur J Hum Genet       Date:  2017-02-08       Impact factor: 4.246

5.  Fragile X carrier screening and FMR1 allele distribution in the Japanese population.

Authors:  Susumu Otsuka; Yumiko Sakamoto; Haruhiko Siomi; Mituo Itakura; Kenji Yamamoto; Hideo Matumoto; Tsukasa Sasaki; Nobumasa Kato; Eiji Nanba
Journal:  Brain Dev       Date:  2009-02-10       Impact factor: 1.961

6.  Do the data really support ordering fragile X testing as a first-tier test without clinical features?

Authors:  Veronique Weinstein; Pranoot Tanpaiboon; Kimberly A Chapman; Nicholas Ah Mew; Sean Hofherr
Journal:  Genet Med       Date:  2017-05-25       Impact factor: 8.822

7.  Common Clinical Characteristics and Rare Medical Problems of Fragile X Syndrome in Thai Patients and Review of the Literature.

Authors:  Chariyawan Charalsawadi; Juthamas Wirojanan; Somchit Jaruratanasirikul; Nichara Ruangdaraganon; Alan Geater; Pornprot Limprasert
Journal:  Int J Pediatr       Date:  2017-06-29

Review 8.  Fragile X Syndrome: Prevalence, Treatment, and Prevention in China.

Authors:  Manman Niu; Ying Han; Angel Belle C Dy; Junbao Du; Hongfang Jin; Jiong Qin; Jing Zhang; Qinrui Li; Randi J Hagerman
Journal:  Front Neurol       Date:  2017-06-06       Impact factor: 4.003

Review 9.  Fragile X syndrome: a review of clinical and molecular diagnoses.

Authors:  Claudia Ciaccio; Laura Fontana; Donatella Milani; Silvia Tabano; Monica Miozzo; Susanna Esposito
Journal:  Ital J Pediatr       Date:  2017-04-19       Impact factor: 2.638

Review 10.  Single-Nucleotide Mutations in FMR1 Reveal Novel Functions and Regulatory Mechanisms of the Fragile X Syndrome Protein FMRP.

Authors:  Joshua A Suhl; Stephen T Warren
Journal:  J Exp Neurosci       Date:  2015-12-08
View more
  1 in total

1.  Cytoplasmic Polyadenylation Element-Binding Protein 1 Post-transcriptionally Regulates Fragile X Mental Retardation 1 Expression Through 3' Untranslated Region in Central Nervous System Neurons.

Authors:  Souichi Oe; Shinichi Hayashi; Susumu Tanaka; Taro Koike; Yukie Hirahara; Ryohei Seki-Omura; Rio Kakizaki; Sumika Sakamoto; Yosuke Nakano; Yasuko Noda; Hisao Yamada; Masaaki Kitada
Journal:  Front Cell Neurosci       Date:  2022-04-15       Impact factor: 6.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.